BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MIT Holding Inc. (MITD) (MITD) Announces Funding And IR Agreement With Wakabayashi Fund LLC


1/15/2014 8:54:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAVANNAH, GA--(Marketwired - January 14, 2014) -

MIT Holding, Inc. (OTCQB: MITD) announces that it has entered into a funding agreement with Wakabayashi Fund LLC, a private equity firm based in Tokyo and New York.

Walter H.C. Drakeford, Co-CEO and Co-President of MIT, stated, "Bringing multiple funding sources to the table enables MIT to explore the best options available for the company. Wakabayashi offers unique funding sources that we believe will compliment the MIT expansion using an acquisition revenue growth strategy."

Wakabayashi Fund, LLC is a private equity fund with offices in Tokyo, Japan and New York, which provides corporate capitalization and institutional investor relations consulting services. Wakabayashi Fund specializes in procuring capital for profitable and emerging small-cap and mid-cap companies, identifying institutional funding sources for its clients.

About MIT Holding, Inc.

Through its wholly owned subsidiaries, MIT distributes wholesale pharmaceuticals in the United States and overseas, administers intravenous infusions and, in Georgia, consults and operates ambulatory centers where therapies are administered and sells and rents home medical equipment. MIT has initiated government contacts to obtain the necessary approvals to import pharmaceutical products into the Dominican Republic, Haiti, Costa Rica, the Bahamas, Argentina, and Brazil. MIT's domestic wholesale pharmaceutical distribution is conducted through Medical Infusion Technologies, Inc., which sells pharmaceuticals to end-users and other wholesalers in the U.S.

For more information, contact Mr. William Nalley, Orsay Groupe, info@orsaygroupe.com, phone 305-790-2688 and/or visit www.mitholdings.com.

Forward-Looking Statements:
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements regarding beliefs, plans, expectations or intentions contain reasonable expectations, but there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate.


Contact
William Nalley
Orsay Groupe
305-790-2688
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES